Celcuity Q3 2024 Earnings Report
Key Takeaways
Celcuity reported a net loss of $29.8 million, or $0.70 loss per share, for the third quarter of 2024, compared to a net loss of $18.4 million, or $0.83 loss per share, for the third quarter of 2023. Total operating expenses were $30.1 million, compared to $18.9 million for the third quarter of 2023.
Enrollment in the VIKTORIA-1 study remains robust and on-track.
The PIK3CA wild-type cohort is 100% enrolled, and enrollment in the PIK3CA mutant cohort is on plan.
Topline data for the PIK3CA wild-type cohort is expected in late Q1 2025 or during Q2 2025.
Topline data for the PIK3CA mutant cohort is expected in the second half of 2025.
Celcuity
Celcuity
Forward Guidance
Celcuity expects to report topline data for the PIK3CA wild-type cohort sometime in late Q1 2025 or during Q2 2025 and to report topline data for the PIK3CA mutant cohort in the second half of 2025.